BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 16297085)

  • 1. Hormone replacement therapy and breast cancer risk in California.
    Coombs NJ; Taylor R; Wilcken N; Fiorica J; Boyages J
    Breast J; 2005; 11(6):410-5. PubMed ID: 16297085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HRT and breast cancer: impact on population risk and incidence.
    Coombs NJ; Taylor R; Wilcken N; Boyages J
    Eur J Cancer; 2005 Aug; 41(12):1775-81. PubMed ID: 16087330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Olsson HL; Ingvar C; Bladström A
    Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of HRT and the subsequent risk of cancer.
    Beral V; Banks E; Reeves G; Appleby P
    J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer and HRT--what are the data?
    Bieber EJ; Barnes RB
    Int J Fertil Womens Med; 2001; 46(2):73-8. PubMed ID: 11374658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy: real concerns and false alarms.
    Bluming AZ; Tavris C
    Cancer J; 2009; 15(2):93-104. PubMed ID: 19390302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy and breast cancer risk in Kyushu University Hospital: supporting the Women's Health Initiative study.
    Nozaki M; Koera K; Nagata H; Nakano H
    J Obstet Gynaecol Res; 2004 Aug; 30(4):297-302. PubMed ID: 15238106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence.
    Verkooijen HM; Bouchardy C; Vinh-Hung V; Rapiti E; Hartman M
    Maturitas; 2009 Oct; 64(2):80-5. PubMed ID: 19709827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of changes in hormone therapy on breast cancer incidence in the US population.
    Coombs NJ; Cronin KA; Taylor RJ; Freedman AN; Boyages J
    Cancer Causes Control; 2010 Jan; 21(1):83-90. PubMed ID: 19795215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current opinions and understandings of menopausal women about hormone replacement therapy (HRT)-the University of Florida experience.
    Levens E; Williams RS
    Am J Obstet Gynecol; 2004 Aug; 191(2):641-6; discussion 646-7. PubMed ID: 15343254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type and duration of exogenous hormone use affects breast cancer histology.
    Kumar AS; Cureton E; Shim V; Sakata T; Moore DH; Benz CC; Esserman LJ; Hwang ES
    Ann Surg Oncol; 2007 Feb; 14(2):695-703. PubMed ID: 17103262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
    Anderson GL; Chlebowski RT; Rossouw JE; Rodabough RJ; McTiernan A; Margolis KL; Aggerwal A; David Curb J; Hendrix SL; Allan Hubbell F; Khandekar J; Lane DS; Lasser N; Lopez AM; Potter J; Ritenbaugh C
    Maturitas; 2006 Sep; 55(2):103-15. PubMed ID: 16815651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormone replacement therapy and the risk of developing breast cancer].
    Merz WE
    MMW Fortschr Med; 2004 Feb; 146(9):26-8, 30. PubMed ID: 15352702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in hormone replacement therapy use and declining breast cancer incidence in the Belgian province of Limburg.
    Vankrunkelsven P; Kellen E; Lousbergh D; Cloes E; Op de Beeck L; Faes C; Bruckers L; Mertens R; Coebergh JW; Van Leeuwen FE; Buntinx F
    Breast Cancer Res Treat; 2009 Nov; 118(2):425-32. PubMed ID: 19238536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing pattern of age-specific breast cancer incidence in the Swiss canton of Geneva.
    Bouchardy C; Usel M; Verkooijen HM; Fioretta G; Benhamou S; Neyroud-Caspar I; Schaffar R; Vlastos G; Wespi Y; Schäfer P; Rapiti E
    Breast Cancer Res Treat; 2010 Apr; 120(2):519-23. PubMed ID: 19633953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the Women's Health Initiative study publication on hormone replacement therapy use among women who have undergone BRCA1/2 testing.
    Dorval M; Vallée MH; Plante M; Chiquette J; Gaudet M; Simard J
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):157-60. PubMed ID: 17220345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estrogen replacement therapy and breast cancer].
    Bakken K; Alsaker E; Eggen AE; Lund E
    Tidsskr Nor Laegeforen; 2005 Feb; 125(3):282-5. PubMed ID: 15702147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy use and variations in the risk of breast cancer.
    Opatrny L; Dell'Aniello S; Assouline S; Suissa S
    BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy.
    Katalinic A; Rawal R
    Breast Cancer Res Treat; 2008 Feb; 107(3):427-30. PubMed ID: 17453336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.